Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stem Cell Technology Helps Repair Heart Damage

By HospiMedica International staff writers
Posted on 26 Jan 2015
A novel minimally invasive nanotechnology solution could improve heart function in as little as two to four weeks. More...


The BioGenerator stem cell device consists of two essential parts: a capsule made of a nanofibrous material that is woven into a scaffold using electrospinning technology, and human stem cells derived from adult bone marrow. Once prepared, the electrospun nanofibrous membrane capsule can either be stitched into the heart muscle wall, or injected into the heart muscle itself through a catheter. Both options are minimally invasive, do not require open heart surgery, and allow the heart to repair itself.

The BioGenerator works by controlling the dispersion of stem cells, while facilitating their removal when needed. But while the stem cells contained within the scaffold cannot escape, molecules such as proteins and growth factors derived from them can move through the membrane into the heart muscle, stimulating cardiac myocytes to grow and repair the damage within the damaged heart. The BioGenerator stem cell device is a product of NuVascular Technologies (Ashland, MA, USA), and was developed in conjunction with the Worcester Polytechnic Institute (WPI; Worcester, MA, USA).

“Our nanofibrous scaffold will ensure that the therapeutic benefit provided by stem cells will be localized directly to the damaged area of the heart,” said Matthew Phaneuf, BSc, founder and chief technical officer of NuVascular Technologies. “We are confident that our devices can provide a minimally invasive, highly effective treatment for heart disease that can actually reverse the damage, rather than providing a temporary solution that often comes with complications.”

Electrospinning is a method of electrostatically depositing polymer nanofibers onto an object. By applying high voltage to a liquid polymer solution—such as polyester or polyurethane—a narrow, microscopic jet of viscous polymer solution is drawn towards a grounded surface. The solvent rapidly evaporates, leaving a solid layer of polymer nanofibers deposited onto the collecting surface. The resulting materials have synergistic microstructural and biological benefits that hold numerous advantages over conventional woven and knitted textile materials.

Related Links:

NuVascular Technologies
Worcester Polytechnic Institute



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.